Elanco Animal Health (ELAN) announced the U.S. Department of Agriculture approval of TruCan Ultra Lyme-L4. It is the first and only 1/2 mL combination vaccine protecting against both Lyme disease and leptospirosis, all in a low-volume dose, for dogs. This combination formulation allows veterinarians to provide essential protection without the need for multiple injections.
The approval follows recent USDA approvals of TruCan Ultra B, and TruCan Ultra CIV H3N2/H3N8. TruCan Ultra Lyme-L4 is expected to begin shipping in the next 30 days.
In pre-market trading on NYSE, Elanco Animal Health shares are up 0.52 percent to $24.30.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
September 04, 2026 15:08 ET The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.